Over the past few years, policy, legal and economic analysis of the complex relationships between genetic resources, biotechnology and intellectual property has multiplied. These relationships are fundamentally based on issues regarding rights over and control of biodiversity and related inventions and innovation. They notoriously confront biodiversity rich countries of the South, with technologically advanced but biodiversity poor countries of the North. Controversies are often captured under the general discussions on access to genetic resources and benefit sharing (ABS), as placed on the agenda by the Convention on Biological Diversity (CBD) after its adoption in 1992.
Print ISSN: 1612-6068
Volume: 3, 11/2006
Pages: 237 - 243